Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1200/GO.23.00418 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
PURPOSE The number of cancer survivors living with and beyond cancer treatment is rising globally. It is fundamental to understand the extent and type of psychosocial care services offered worldwide. We evaluated models of cancer survivorship care, psychosocial care practices in the post-treatment survivorship phase, and barriers/facilitators to delivery of psychosocial care services, including in low- and middle-income countries (LMICs). METHODS The International Psycho-Oncology Society (IPOS) Survivorship Special Interest Group led a cross-sectional online survey between March and November 2022. Health care professionals and researchers in psycho-oncology were invited through the IPOS global membership, social media, and snowballing. The survey was administered to individuals but included questions related to practices in their country at a national level. RESULTS Two hundred eighty-three respondents from 37 countries participated (40% from LMICs), with a median of 12 years of experience (IQR, 6-20) in the psycho-oncology field. Participants reported that the most common elements of routine survivorship care were related to the prevention/ management of recurrences/new cancers (74%), physical late effects (59%), and chronic medical conditions (53%), whereas surveillance/ management of psychosocial late effects (27%) and psychosocial/ supportive care (25%) were least common. Service availability was more commonly reported in high-income countries (HICs) than LMICs related to reproductive health (29% v 17%), genetic counseling/support (40% v 20%), and identifying/managing distress (39% v 26%) and pain (66% v 48%). Key barriers included providers focusing on treatment not survivorship (57%), medical not psychosocial care (60%), and a lack of allied health providers to deliver psychosocial care (59%). CONCLUSION The psychosocial needs of people living with cancer are not adequately available and/or provided in post-treatment survivorship even in HICs, because of barriers at patient, provider, and system levels.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Signorelli, Christina | - |
UNSW Medicine - Australia
Sydney Children's Hospital, Randwick - Australia UNSW Sydney - Australia Sydney Childrens Hosp - Australia |
| 2 | Høeg, Beverley Lim | - |
Danish Canc Inst - Dinamarca
Danish Cancer Institute - Dinamarca |
| 3 | Asuzu, Chioma | - |
College of Medicine, University of Ibadan - Nigeria
Coll Med - Nigeria |
| 4 | Centeno, Isabel | - |
Hospital Zambrano Hellion TecSalud - México
Hosp Zambrano Hellion - México |
| 5 | Estapé, Tania | - |
FEFOC Foundation - España
FEFOC Fdn - España |
| 6 | Fisher, Peter | - |
University of Liverpool - Reino Unido
UNIV LIVERPOOL - Reino Unido Liverpool Univ Hosp NHS Fdn Trust - Reino Unido |
| 7 | Lam, Wendy | - |
The University of Hong Kong Li Ka Shing Faculty of Medicine - Hong Kong
Univ Hong Kong - China |
| 8 | Levkovich, Inbar | - |
Oranim Academic College of Education - Israel
Oranim Acad Coll Educ - Israel |
| 9 | Manne, Sharon | - |
Rutgers Robert Wood Johnson Medical School at New Brunswick - Estados Unidos
RUTGERS STATE UNIV - Estados Unidos |
| 10 | Miles, Anne | - |
University of London - Reino Unido
UNIV LONDON - Reino Unido Birkbeck, University of London - Reino Unido |
| 11 | Mullen, Louise | - |
Health Service Executive Ireland - Irlanda
Natl Canc Control Programme - Irlanda |
| 12 | Nekhlyudov, Larissa | - |
Harvard Medical School - Estados Unidos
Harvard Med Sch - Estados Unidos |
| 13 | Sade, Cristina | - |
Instituto Nacional del Cáncer, Chile - Chile
Inst Nacl Canc - Chile |
| 14 | Shaw, Joanne | - |
The University of Sydney - Australia
UNIV SYDNEY - Australia |
| 15 | Singleton, Anna | - |
Faculty of Medicine and Health - Australia
UNIV SYDNEY - Australia |
| 16 | Travado, Luzia | - |
Champalimaud Foundation - Portugal
Champalimaud Fdn - Portugal |
| 17 | Tsuchiya, Miyako | - |
National Cancer Center Japan - Japón
Musashino University - Japón Natl Canc Ctr - Japón Musashino Univ - Japón |
| 18 | Lemmen, Jesse | - |
Vrije Universiteit Amsterdam - Países Bajos
Princess Máxima Center for Pediatric Oncology - Países Bajos Vrije Univ Amsterdam - Países Bajos Princess Maxima Ctr Pediat Oncol - Países Bajos |
| 19 | Li, Jie | - |
Shandong University - China
Shandong Univ - China |
| 20 | Jefford, Michael | - |
Peter Maccallum Cancer Centre - Australia
University of Melbourne - Australia Peter MacCallum Canc Ctr - Australia Univ Melbourne - Australia |
| 21 | Int Psychooncol Soc Survivorship Special Interest Grp | Corporación | |
| 21 | Altman, Shiri | - | |
| 22 | Anang, Reginald | - | |
| 24 | Barrera, Maru | - | |
| 25 | Basen-Engquist, Karen | - | |
| 26 | Bidstrup, Pernille | - | |
| 27 | Bilodeau, Karine | - | |
| 29 | Christodoulidou, Stephanie | - | |
| 30 | Cirila, Andreja | - | |
| 31 | Cohee, Andrea | - | |
| 32 | Dégi, László Csaba | - | |
| 33 | Dhillon, Haryana | - | |
| 34 | Duijts, Saskia | - | |
| 37 | Foster, Claire | - | |
| 38 | Fournier, Valentyn | - | |
| 39 | Gitonga, Isaiah | - | |
| 40 | Goswami, Savita | - | |
| 41 | Ha, Lauren | - | |
| 42 | Hack, Tom | - | |
| 43 | Heathcote, Lauren | - | |
| 44 | Howard, Fuchsia | - | |
| 45 | Hulbert-Williams, Nicholas | - | |
| 46 | Jacobsen, Paul | - | |
| 48 | Kassianos, Angelos P. | Hombre | |
| 49 | Koczwara, Bogda | - | |
| 51 | Lasebikan, Victor | - | |
| 52 | Lebel, Sophie | - | |
| 54 | Leslie, Monica | - | |
| 58 | Liu, Xiaohong | - | |
| 59 | Luigjes, Yvonne | - | |
| 61 | Martinez Tyson, Dinorah | - | |
| 62 | Mazariego, Carolyn | - | |
| 64 | Mirov, Yurii | - | |
| 66 | Nandakumar, Devi | - | |
| 67 | Larissa Nekhlyudo, Ray Nascimento | - | |
| 68 | Odiyo, Philip | - | |
| 69 | Ortolan, Paula | - | |
| 70 | Reshetova, Maria | - | |
| 71 | Ruble, Kathy | - | |
| 76 | Smith, Ben | - | |
| 77 | Smrdel, Škufca | - | |
| 78 | Taylor, Carolyn | - | |
| 81 | Turner, Jane | - | |
| 82 | Veeraiah, Surendran | - | |
| 83 | Wells, Elizabeth | - | |
| 84 | Xu, Lei | - | |
| 85 | Zhang, Anao | - |
| Fuente |
|---|
| National Natural Science Foundation of China |
| National Health and Medical Research Council |
| NHMRC |
| Cancer Institute NSW |
| Cancer Institute NSW Early Career Fellowship |
| Savita Goswami |
| Agradecimiento |
|---|
| Supported by a Cancer Institute NSW Early Career Fellowship (2020/ECF1144; C.S.). A.S. was supported by a NHMRC Emerging Leadership Level 1 Investigator Grant EL1 (Award ID GNT2017575). J.L. wassupported by the National Natural Science Foundation of China (72004119). |
| Supported by a Cancer Institute NSW Early Career Fellowship (2020/ECF1144; C.S.). A.S. was supported by a NHMRC Emerging Leadership Level 1 Investigator Grant EL1 (Award ID GNT2017575). J.L. was supported by the National Natural Science Foundation of China (72004119). |